Form 4: Dexcom President Reports Stock Transaction
Insider Transaction (Form 4)
Jacob Steven Leach, President, CEO, and Director and a Director of Dexcom Inc, reported a transaction in 1,451 shares of common stock on August 22, 2026.
Summary
- Tax/exercise-price withholding: disposed of 1,451 Common Stock at $92.34 ($133,985) on August 22, 2026; holds 418,908 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jacob Steven Leach — Director, Officer (President, CEO, and Director)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-22 | Tax/exercise-price withholding | Common Stock | 1,451 | $92 | $134.0K | 418,908 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-22 | Tax/exercise-price withholding (1,451 shares) |
Keywords
insider transaction, Form 4, DXCM, DEXCOM INC, neutral, Jacob Steven Leach
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.